Pre-exposure prophylaxis for HIV infection and new sexually transmitted infections among men who have sex with men

AIDS

Volumn 30, Issue 14, 2016, Pages 2251-2252

  Kojima, Noah ^a   Davey, Dvora Joseph ^a,b   Klausner, Jeffrey D ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ANTIVIRAL THERAPY; ARTICLE; CHLAMYDIASIS; GONORRHEA; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MEN WHO HAVE SEX WITH MEN; PRE-EXPOSURE PROPHYLAXIS; PRIORITY JOURNAL; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; SYSTEMATIC REVIEW; DISEASE TRANSMISSION; INCIDENCE; MALE; MALE HOMOSEXUALITY; META ANALYSIS; PREVENTION AND CONTROL; TRANSMISSION;

DISEASE TRANSMISSION, INFECTIOUS; HOMOSEXUALITY, MALE; HUMANS; INCIDENCE; MALE; PRE-EXPOSURE PROPHYLAXIS; SEXUALLY TRANSMITTED DISEASES;

EID: 84975143410     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000001185     Document Type: Article

References (9)

1. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med 2010; 363:2587-2599.
2. McCormack S, Dunn DT, Desai M, Dolling DI, Gafos M, Gilson R, et al. Preexposure prophylaxis to prevent the acquisition of HIV-1 infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial. Lancet 2016; 387:53-60.
3. Scott HM, Klausner JD. Sexually transmitted infections and preexposure prophylaxis: challenges and opportunities among men who have sex with men in the US. AIDS Res Ther 2016; 13:5.
4. Koester KA, Grant RM. Editorial commentary: keeping our eyes on the prize: no new HIV infections with increased use of HIV pre-exposure prophylaxis. Clin Infect Dis 2015; 61:1604-1605.
5. Volk JE, Marcus JL, Phengrasamy T, Blechinger D, Nguyen DP, Follansbee S, Hare CB. No new HIV infections with increasing use of HIV preexposure prophylaxis in a clinical practice setting. Clin Infect Dis 2015; 61:1601-1603.
6. Paz-Bailey G, Mendoza M, Finlayson T, Wejnert C, Le B, Rose C, et al. Trends in condom use among men who have sex with men in the United States: the role of antiretroviral therapy and sero-adaptive strategies. AIDS 2016.
7. Centers for Disease Control and Prevention. Preexposure pro-phylaxis for the prevention of HIV infection in the United States-2014 a clinical practice guideline. Atlanta, GA: US Department of Health and Human Services, CDC. Available at: http://www. cdc.gov/hiv/pdf/prepguidelines2014.pdf
8. Golub SA, Boonrai K, Douglas N, Hunt M, Radix A. STI Data From Community-Based PrEP Implementation Suggest Changes to CDC Guidelines. Boston, MA: CROI; 2016.
9. Liu AY, Cohen SE, Vittinghoff E, Anderson PL, Doblecki-Lewis S, Bacon O, et al. Preexposure prophylaxis for HIV infection integrated with municipal-and community-based sexual health services. JAMA Intern Med 2016; 176:75-84.